Related
Belgium’s Participation in Expo 2025: Strengthening the Life Sciences Partnership
In January 2024, the Embassy of Belgium in Japan hosted a networking event in Osaka, introducing the Belgian life sciences sector to the Kansai region. This event served as a prelude to Belgium's participation in the upcoming World Expo 2025 in Osaka, where the country will focus on showcasing its strengths in areas like healthcare, biotechnology, and pharmaceuticals.
PITCHING WEBINAR
07
Mar
2024
Biocat, The Catalan Healthcare Cluster, Explores the Japanese Lifescience Ecosystem
Biocat, the Catalan Healthcare Cluster, is actively engaging with the Japanese Lifescience ecosystem through its participation in BioJapan 2023 and meetings held during the Osaka partnering event.
Japan Science and Technology Agency and the European Molecular Biology Organization sign a Memorandum of Cooperation
On 24 July 2023 at Japan Science and Technology Agency (JST)’s Tokyo Headquarters, Kazuhito Hashimoto, President of JST, and Dr. Fiona Watt, President of the European Molecular Biology Organization (EMBO), signed a Memorandum of Cooperation.
Health Campus Limburg, an initiative of POM Limburg, and Osaka Bio Headquarters reach an agreement
Health Campus Limburg, the new health & life sciences campus in Belgian Limburg, and Osaka Bio Headquarters, a bureau of industry-academia-government collaboration responsible for accelerating the growth of life-science industry in Osaka, agreed on the memorandum of understanding to foster connections between Flanders and Osaka.
Seminar report: Looking Beyond the Horizon
Seminar details
Looking Beyond the Horizon
13
Nov
2017
Future EU-Japan Collaboration on Research and Innovation
Northern Osaka Biomedical Cluster

An outline of Northern Osaka Biomedical Cluster

Located on the hillside of northern part of Osaka, the Northern Osaka Biomedical Cluster illustrates a highest potential in life science.

PMK initiative

Presentation of a Japanese Cluster - PMK initiative

The Kansai region (Osaka, Kobe and Kyoto metropolitan areas) is the heart of Japan’s biotech industry and is home to top biomedical clusters that are open to the international community.

These clusters feature many pharmaceutical companies, medical institutions, bio ventures, and research institutions.

The Kansai region offers an excellent environment perfectly suited for partnering in areas ranging from exploratory research in drug discovery to production and sales of pharmaceuticals. 

Case Study: HealthCapital: A German Cluster
HEALTHCAPITAL - from DE

EU-Japan Centre's News

More
Japan Science and Technology Agency (JST) has pre-announced a call for applications for the 2024…
The Horizon Europe call for EU-Japan collaboration projects (Topic: HORIZON-JU-SNS-2024-STREAM-B-01…
The EU-Japan Centre’s office in Tokyo is regularly publishing "Industry and Policy News”. By…
The European Institute of Innovation & Technology invites you to apply to their one-of-a-kind,…
The EU-Japan Centre is pleased to start a new weekly service by publishing brief summary of the…

Events

More
Online and in Japan
17/06/2024 - 12/07/2024
17-21 June 2024, → mandatory week online (open to SMEs and large companies) 08-12 July 2024, → optional week in Japan (open only to SMEs who have completed the first online week) PROGRAMME…
Japan
01/08/2024 - 31/03/2025
  The organization of the Vulcanus Programme is pending reception of a grant by the EU-Japan Centre for Industrial Cooperation for the Japanese fiscal year 2024-2025: Please note that this call is…
Subscribe to
our newsletters

The EU-Japan Centre currently produces 5 newsletters :

  • EU-Japan NEWS - our flagship newsletter covering the Centre's support services, information about EU (or Member States) - Japan cooperation
  • Japanese Industry and Policy News
  • “About Japan” e-News (Only available for EU companies / EU organisations)
  • Japan Tax and Public Procurement Weekly Tender Digest (Only available for EU companies / EU organisations)
  • Tech Transfer Helpdesk Newsletter
Subscribe